Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 20/20 | 0.70 |
| ▸ | NSD2 | O96028 | 1/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.62 |
| ▸ | BID | P55957 | 1/20 | 0.62 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.62 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.62 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.62 |
| ▸ | ASPH | Q12797 | 1/20 | 0.62 |
| ▸ | BCL2L2 | Q92843 | 1/20 | 0.62 |
| ▸ | BAD | Q92934 | 1/20 | 0.62 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.62 |
| ▸ | NSD3 | Q9BZ95 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24519990 | 0.91 | BCL2 (0.70) | BCL2NSD2ADORA3CYP2C9ADRA2C | |
| SCHEMBL21573198 | 0.91 | BCL2 (0.71) | BCL2BCL2L1MCL1BCL2L2 | |
| SCHEMBL20580603 | 0.91 | BCL2 (0.82) | BCL2NSD2ADORA3CYP2C9ADRA2C | |
| SCHEMBL29375954 | 0.91 | BCL2 (0.82) | BCL2NSD2ADORA3CYP2C9ADRA2C | |
| SCHEMBL19853638 | 0.90 | BCL2 (0.83) | BCL2NSD2ADORA3CYP2C9ADRA2C | |
| SCHEMBL21573183 | 0.89 | BCL2 (0.69) | BCL2 | |
| SCHEMBL22562885 | 0.89 | BCL2 (0.74) | BCL2NSD2ADORA3CYP2C9ADRA2C | |
| SCHEMBL22562900 | 0.89 | BCL2 (0.71) | BCL2 | |
| SCHEMBL21573199 | 0.89 | BCL2 (0.71) | BCL2 | |
| SCHEMBL21573167 | 0.88 | BCL2 (0.83) | BCL2NSD2ADORA3CYP2C9ADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3672595-B1 | COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES | ASCENTAGE PHARMA SUZHOU CO LTD (CN) | 2021-07-21 | — | — | EP | disclosed |
| EP-3569601-A2 | N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | The Regents of The University of Michigan (US) | 2019-11-20 | — | — | EP | disclosed |
| WO-2018027097-A1 | N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2018-02-08 | — | — | WO | disclosed |